Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.

Parsian A, Racette B, Goldsmith LJ, Perlmutter JS.

Genomics. 2002 Mar;79(3):458-61.

PMID:
11863377
2.

APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease.

Huang X, Chen PC, Poole C.

Neurology. 2004 Jun 22;62(12):2198-202. Review.

PMID:
15210882
3.

Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.

Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Capurso A, Panza F.

Exp Gerontol. 2004 Oct;39(10):1567-73. Review.

PMID:
15501028
4.

Genetic predictors of common disease: apolipoprotein E genotype as a paradigm.

Jarvik GP.

Ann Epidemiol. 1997 Jul;7(5):357-62. Review.

PMID:
9250631
5.

Genetic factors in the etiology of idiopathic Parkinson's disease.

Vieregge P.

J Neural Transm Park Dis Dement Sect. 1994;8(1-2):1-37. Review.

PMID:
7893371
6.

Dementia in Parkinson's disease.

Korczyn AD.

J Neurol. 2001 Sep;248 Suppl 3:III1-4. Review.

PMID:
11697682
7.

Gene-environment interaction in late-onset Alzheimer disease: the role of apolipoprotein-epsilon4.

Mayeux R.

Alzheimer Dis Assoc Disord. 1998;12 Suppl 3:S10-5. Review. No abstract available.

PMID:
9876937
8.

Nonmotor symptoms in genetic Parkinson disease.

Kasten M, Kertelge L, Br├╝ggemann N, van der Vegt J, Schmidt A, Tadic V, Buhmann C, Steinlechner S, Behrens MI, Ramirez A, Binkofski F, Siebner H, Raspe H, Hagenah J, Lencer R, Klein C.

Arch Neurol. 2010 Jun;67(6):670-6. doi: 10.1001/archneurol.67.6.670. Review.

PMID:
20558386
9.

Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review.

Maiti TK, Konar S, Bir S, Kalakoti P, Bollam P, Nanda A.

Neurosurg Focus. 2015 Nov;39(5):E3. doi: 10.3171/2015.8.FOCUS15329. Review.

PMID:
26646927
10.

Will testing for apolipoprotein E assist in tailoring dementia risk reduction? A review.

Low LF, Yap MH, Brodaty H.

Neurosci Biobehav Rev. 2010 Mar;34(3):408-37. doi: 10.1016/j.neubiorev.2009.08.007. Epub 2009 Aug 29. Review.

PMID:
19720080
12.

The effects of APOE genotype on age at onset and progression of neurodegenerative diseases.

Chapman J, Korczyn AD, Karussis DM, Michaelson DM.

Neurology. 2001 Oct 23;57(8):1482-5. Review.

PMID:
11673593
13.

Environmental factors in the etiology of Parkinson's disease.

Tanner CM, Chen B, Wang WZ, Peng ML, Liu ZL, Liang XL, Kao LC, Gilley DW, Schoenberg BS.

Can J Neurol Sci. 1987 Aug;14(3 Suppl):419-23. Review.

PMID:
3315147
14.

The impact of dementia development concurrent with Parkinson's disease: a new perspective.

Russell A, Drozdova A, Wang W, Thomas M.

CNS Neurol Disord Drug Targets. 2014;13(7):1160-8. Review.

PMID:
25230219
15.

Genetic epidemiology of Parkinson's disease.

Payami H, Zareparsi S.

J Geriatr Psychiatry Neurol. 1998 Summer;11(2):98-106. Review.

PMID:
9877530
16.

[Dementia--a genetic disease?].

Tolnay M.

Praxis (Bern 1994). 2000 Sep 7;89(36):1422-4. Review. German. No abstract available.

PMID:
11031858
17.

Diagnosis of presenile dementia.

Doran M.

Br J Hosp Med. 1997 Jul 9-Aug 19;58(2-3):105-10. Review.

PMID:
9349377
18.

Initial evaluation of suspected dementia. Asking the right questions.

Steffens DC, Morgenlander JC.

Postgrad Med. 1999 Oct 15;106(5):72-6, 79-80, 82-3. Review.

PMID:
10560469
19.

Relationship between Apolipoprotein Superfamily and Parkinson's Disease.

Li L, Liu MS, Li GQ, Tang J, Liao Y, Zheng Y, Guo TL, Kang X, Yuan MT.

Chin Med J (Engl). 2017 Nov 5;130(21):2616-2623. doi: 10.4103/0366-6999.217092. Review.

20.

Chronic dementing conditions, genomics, and new opportunities for nursing interventions.

Schutte DL, Holston EC.

J Nurs Scholarsh. 2006;38(4):328-34. Review.

PMID:
17181080

Supplemental Content

Support Center